Research Article

Predicting the Incidence and Prognosis of Bone Metastatic Breast Cancer: A SEER-Based Observational Study

Table 4

Median survival time of bone metastasis cancer patients according to molecular subtype and patient characteristics.

CharacteristicsLuminal ALuminal BHER2+TNBC value
(HR+/Her2-)(HR+/Her2+)(HR-/Her2+)(HR-/Her2-)
Median95% CIMedian95% CIMedian95% CIMedian95% CI

All1917.724-20.2762016.779-23.221106.887-13.11397.828-10.172<0.001
Age
 <402721.289-32.7112520.429-29.571199.532-28.468139.832-16.168<0.001
 40-592422.144-25.8562419.463-28.537126.792-17.208108.263-11.737<0.001
 ≥601513.553-16.447148.137-19.86362.017-9.98375.530-8.470<0.001
value<0.001<0.0010.1770.003
Race
 White1917.446-20.5541914.887-23.113116.617-15.38397.714-10.286<0.001
 Black1613.831-18.1692217.254-26.74683.118-12.882108.013-11.987<0.001
 Other2420.056-27.94470-22.245120-24.83472.340-11.6600.006
value<0.0010.5940.4220.971
Grade
 1-22220.406-23.5941912.275-25.725114.575-17.42585.613-10.387<0.001
 3-41614.645-17.3552016.340-23.660106.405-13.59597.754-10.246<0.001
value<0.0010.9960.7390.736
T stage
 0-22220.445-23.5552319.581-26.419103.607-16.393107.712-12.288<0.001
 3-41715.409-18.5911711.878-22.122106.933-13.06797.671-10.329<0.001
value<0.0010.1170.3410.114
N stage
 0-11816.455-19.5451712.033-21.96795.656-12.34486.697-9.303<0.001
 2-32118.792-23.2082218.577-25.423168.355-23.645108.013-11.987<0.001
value0.0420.5770.0380.487
Brain metastasis
 No2119.732-22.2682118.027-23.973127.380-16.62097.731-10.269<0.001
 Yes74.822-9.17894.756-13.24461.637-10.36364.522-7.4780.002
value<0.0010.0030.0020.001
Liver metastasis
 No2220.623-23.3772522.414-27.586116.905-15.095119.673-12.327<0.001
 Yes119.013-12.98794.945-13.05593.404-14.59664.623-7.377<0.001
value<0.001<0.0010.008<0.001
Lung metastasis
 No2220.661-23.3392117.898-24.1021812.664-23.336108.388-11.612<0.001
 Yes1210.108-13.892147.818-20.18252.403-7.59774.663-9.337<0.001
value<0.0010.081<0.0010.002